U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Vaccines, Blood & Biologics
  3. Blood & Blood Products
  4. Approved Blood Products
  5. NUWIQ
  1. Approved Blood Products

STN: BL 125555
Proper Name: Antihemophilic Factor (Recombinant)
Tradename: NUWIQ
Manufacturer: Octapharma USA, Inc.

Indication:

  • Indicated in adults and children with Hemophilia A for:
    • On-demand treatment and control of bleeding episodes
    • Perioperative management of bleeding
    • Routine prophylaxis to reduce the frequency of bleeding episodes

Product Information

Supporting Documents

Back to Top